Stay updated on Efficacy of HZN-825 in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of HZN-825 in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Efficacy of HZN-825 in Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check6 days agoChange DetectedAdded 'Results Posted' on 2025-12-03 for NCT05032066, including EU CTIS number 2023-509784-24-00. Expanded the Study Plan with detailed Core Phase and Extension Phase outcomes (e.g., FVC changes at Week 52 and Week 104) and multiple secondary measures (6MWT, K-BILD, L-IPF, LCQ, hospitalization and PFS), plus related documents (Study Protocol and SAP).SummaryDifference3%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on this page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedThe site-wide notice about government funding and NIH Clinical Center operating status was removed. Core trial information remains unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedMinor UI/layout updates to the Study Details page, with no changes to core study information such as eligibility criteria, outcomes, enrollment, or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check70 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference2%

- Check77 days agoChange DetectedThe page now announces Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, etc.), signaling a scope change with a new versioning label.SummaryDifference0.2%

Stay in the know with updates to Efficacy of HZN-825 in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of HZN-825 in Idiopathic Pulmonary Fibrosis Clinical Trial page.